Chunxiang Wu

Chunxiang Wu

Auto-generated profile, based on publicly available information

Chunxiang Wu

Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2023 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
QSQi Shen
Qi Shen
QFQingzhou Feng
Qingzhou Feng
CWChunxiang Wu
Chunxiang Wu
QXQiancheng Xiong
Qiancheng Xiong
TTTaoran Tian
Taoran Tian
YXYong Xiong
Yong Xiong

28 December 2022 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
QSQi Shen
Qi Shen
QXQiancheng Xiong
Qiancheng Xiong
KZKaifeng Zhou
Kaifeng Zhou
QFQingzhou Feng
Qingzhou Feng
LLLongfei Liu
Longfei Liu
CLChenxiang Lin
Chenxiang Lin

21 March 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
QSQi Shen
Qi Shen
SKSushila Kumari
Sushila Kumari
CXChaoyi Xu
Chaoyi Xu
SJSooin Jang
Sooin Jang
JSJiong Shi
Jiong Shi
YXYong Xiong
Yong Xiong
Increasing evidence has suggested that the HIV-1 capsid enters the nucleus in a largely assembled, intact form. However, not much is known about how the cone-shaped capsid interacts with the nucleoporins (NUPs) in the nuclear pore for crossing the nuclear pore complex. Here, we elucidate how NUP153 binds HIV-1 capsid by engaging the assembled capsid protein (CA) lattice. A bipartite motif containing both canonical and noncanonical interaction modules was identified at the C-terminal tail region of NUP153. The canonical cargo-targeting phenylalanine-glycine (FG) motif engaged the CA hexamer. By contrast, a previously unidentified triple-arginine (RRR) motif in NUP153 targeted HIV-1 capsid at the CA tri-hexamer interface in the capsid. HIV-1 infection studies indicated that both FG- and RRR-motifs were important for the nuclear import of HIV-1 cores. Moreover, the presence of NUP153 stabilized tubular CA assemblies in vitro. Our results provide molecular-level mechanistic evidence that NUP153 contributes to the entry of the intact capsid into the nucleus.

15 November 2024 in Science Advances
Verified
Journal Article
Open access
QFQingzhou Feng
Qingzhou Feng
MSMartin Saladin
Martin Saladin
CWChunxiang Wu
Chunxiang Wu
ECEason Cao
Eason Cao
WZWei Zheng
Wei Zheng
CLChenxiang Lin
Chenxiang Lin
Nucleoporins (nups) in the nuclear pore complex (NPC) form a selective barrier that suppresses the diffusion of most macromolecules while enabling rapid transport of nuclear transport receptor (NTR)–bound cargos. Recent studies have shown that the NPC may dilate and constrict, but how altering the NPC diameter affects its selective barrier properties remains unclear. Here, we build DNA nanopores with programmable diameters and nup arrangements to model the constricted and dilated NPCs. We find that Nup62 proteins form a dynamic cross-channel barrier impermeable to hepatitis B virus (HBV) capsids when grafted inside 60-nm-wide nanopores but not in 79-nm pores, where Nup62 cluster locally. Furthermore, importin-β1 substantially changes the dynamics of Nup62 assemblies and facilitates the passage of HBV capsids through the 60-nm NPC mimics containing Nup62 and Nup153. Our study shows that transport channel width is critical to the permeability of nup barriers and underscores NTRs’ role in dynamically remodeling nup assemblies and mediating the nuclear entry of viruses.

28 March 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
LPLei Peng
Lei Peng
YHYingxia Hu
Yingxia Hu
MMMadeleine C. Mankowski
Madeleine C. Mankowski
PRPing Ren
Ping Ren
RCRita E. Chen
Rita E. Chen
SCSidi Chen
Sidi Chen
COVID-19 pathogen SARS-CoV-2 has infected hundreds of millions and caused over 5 million deaths to date. Although multiple vaccines are available, breakthrough infections occur especially by emerging variants. Effective therapeutic options such as monoclonal antibodies (mAbs) are still critical. Here, we report the development, cryo-EM structures, and functional analyses of mAbs that potently neutralize SARS-CoV-2 variants of concern. By high-throughput single cell sequencing of B cells from spike receptor binding domain (RBD) immunized animals, we identify two highly potent SARS-CoV-2 neutralizing mAb clones that have single-digit nanomolar affinity and low-picomolar avidity, and generate a bispecific antibody. Lead antibodies show strong inhibitory activity against historical SARS-CoV-2 and several emerging variants of concern. We solve several cryo-EM structures at ~3 Å resolution of these neutralizing antibodies in complex with prefusion spike trimer ectodomain, and reveal distinct epitopes, binding patterns, and conformations. The lead clones also show potent efficacy in vivo against authentic SARS-CoV-2 in both prophylactic and therapeutic settings. We also generate and characterize a humanized antibody to facilitate translation and drug development. The humanized clone also has strong potency against both the original virus and the B.1.617.2 Delta variant. These mAbs expand the repertoire of therapeutics against SARS-CoV-2 and emerging variants.

6 November 2025 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
CWChunxiang Wu
Chunxiang Wu
MMMegan E. Meuser
Megan E. Meuser
JRJuan S. Rey
Juan S. Rey
HMHamed Meshkin
Hamed Meshkin
RYRachel Yang
Rachel Yang
YXYong Xiong
Yong Xiong